BioSpace News Archive

Kubota Vision Inc. (“Kubota Vision”), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), today announced the successful completion of a proof-of-concept (POC) clinical study using a wearable myopia control device based on Kubota Glasses technology.

Biocom Institute, a 501(c)(3) non-profit that supports life science innovation by strengthening the workforce and leaders of tomorrow, today announced a partnership with Illumina and the Illumina Foundation to advance the Illumina Genomic Discoveries Educator Program & Curriculum.

Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that it has enrolled the first two patients for its first-in-human CoreoGraft study.

Recordati Rare Diseases Inc., today announced the U.S. Food and Drug Administration (FDA) has approved CYSTADROPS® (cysteamine ophthalmic solution) 0.37%. CYSTADROPS is a new, viscous eye drop solution that depletes corneal cystine crystal deposits in people living with cystinosis

In response to recent national backlogs of COVID-19 testing, Northwest Laboratory (NWL) has announced additional testing capacity to help alleviate shortages.

Avinger, Inc. announced the closing of an underwritten public offering of 11,063,830 shares of its common stock at a price of $0.47 per share, for total gross proceeds of approximately $5.2 million, before deducting underwriting discounts, commissions and other offering expenses payable by the Company.

Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) today announced the call in information and an updated agenda for the shareholder conference call on Wednesday, August 26th at 9:30 am.

Oxford Finance LLC, a specialty finance firm that provides senior debt to life sciences and healthcare services companies worldwide, has announced that on July 15, 2020, it closed a $10 million senior secured term loan with Inhibrx, Inc., a clinical-stage biotechnology company focused on developing a broad pipeline of novel biologic therapeutic candidates.

Pediatric clinical staff and those in their care will soon benefit from a new relationship announced between Medline and Texas Children’s Hospital, a U.S. News & World Report Best Children’s Hospital Honor Roll organization.

Premier Medical Laboratory Services (PMLS) is now offering saliva based COVID-19 diagnostic testing. An industry leading commercial diagnostic laboratory, PMLS is now able to provide diagnostic results based on samples from various specimen types including: saliva, nasopharyngeal swabs, nares swabs, sputum, nasal aspirate, and more.